Flagship Pioneering and ProFound Therapeutics Team Up with Pfizer to Discover Novel Therapies to Treat Obesity
Shots:
- Flagship Pioneering and ProFound Therapeutics have entered into an agreement with Pfizer to discover new first-in-class therapeutics for addressing obesity
- Pioneering Medicines (Flagship Pioneering’s in-house drug development unit) will discover the potential drug development programs based on Flagship's bioplatforms and modalities
- The partnership will further leverage ProFound’s ProFoundry Platform with Pioneering Medicines for the discovery and assessment of novel proteins. Pfizer gains the option to further develop the candidates after assessment as per its strategic partnership with Flagship
Ref: PR Newswire | Image: Flagship Pioneering
Related News:- Profound Medical’s Contouring Assistant AI Module Gains the US FDA’s Approval for Creating Automated TULSA Treatment Plan
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
